Table 5 Characteristics of individual studies of KRAS and GNAS mutations in patients with IPMN according to the microscopic duct types
Study | KRAS mutation (mutation/total) (%) | GNAS mutation (mutation/total) (%) | ||||||
|---|---|---|---|---|---|---|---|---|
Gastric | Pancreato biliary | Intestinal | Oncocytic | Gastric | Pancreato biliary | Intestinal | Oncocytic | |
Amato E | 5/6 (83) | 3/3 (100) | 14/36 (39) | 2/3 (67) | 6/6 (100) | 1/3 (33) | 30/36 (83) | 1/3 (33) |
Chadwick B | 16/19 (84) | 6/7 (86) | 15/26 (58) | Â | Â | Â | Â | Â |
Fritz S | 7/10 (70) | Â | 1/7 (14) | 0/2 (0) | Â | Â | Â | Â |
Hosada W | 40/55 (73) | 6/7 (86) | 12/27 (44) | 1/2 (50) | 34/55 (62) | 0/7 (0) | 21/27 (74) | 0/2 (0) |
Jang JY | 5/13 (38) | 4/8 (50) | 4/19 (21) | Â | Â | Â | Â | Â |
Kuboki Y | 63/97 (65) | 7/11 (64) | 25/56 (45) | 1/8 (13) | 45/97 (46) | 3/11 (27) | 33/56 (59) | 1/8 (13) |
Mohri D | 9/11 (82) | 1/1 (100) | 3/11 (27) | 1/2 (50) | Â | Â | Â | Â |
Singhi AD | 30/40 (75) | 3/5 (60) | 2/5 (40) | Â | 13/40 (33) | 0/5 (0) | 5/5 (100) | Â |
Tan MC | 8/10 (80) | 10/16 (63) | 17/27 (63) | Â | 5/10 (50) | 5/16 (31) | 20/27 (74) | Â |
Wu J | 45/52 (87) | 7/7 (100) | 6/13 (46) | Â | 34/52 (65) | 3/7 (43) | 13/13 (100) | Â |